Oral Thrush Diagnosis and Treatment

Clinical Manifestations

The American College of Physicians recommends recognizing oral thrush by its characteristic white plaque-like lesions on oral mucosa, often accompanied by pain, altered taste, and difficulty eating or swallowing 1, 2
Oral thrush presents with three main clinical patterns: pseudomembranous candidiasis, erythematous candidiasis, and angular cheilitis, which can be identified by their distinct symptoms and appearances 3, 4
Common symptoms of oral thrush include pain and burning sensation in the mouth, altered taste sensation, and white patches that may bleed when scraped 1, 2, 3, 4

Diagnosis of oral thrush is typically made clinically based on the characteristic appearance of lesions, with a strength of evidence rated as high 1
Visual examination of the oral cavity is usually sufficient for diagnosis, but scraping of lesions for microscopic examination or culture may be performed in refractory cases 4, 1
Response to antifungal therapy can be diagnostic in some cases, with a reported response rate of 80-90% 1

The Infectious Diseases Society of America recommends fluconazole 200-400 mg (3-6 mg/kg) daily for 7-14 days as first-line therapy for most cases of oral thrush, with a strength of evidence rated as high 1, 2
Topical options for mild cases or when systemic therapy is contraindicated include clotrimazole troches 10 mg 5 times daily, nystatin suspension or pastilles multiple times daily, and miconazole 50 mg mucoadhesive buccal tablets once daily 1, 5
For refractory cases, itraconazole oral solution 200 mg daily, posaconazole suspension, and voriconazole may be necessary, with reported response rates of 64-80% and 75% respectively 1, 2

For HIV-infected patients, antiretroviral therapy is strongly recommended to reduce recurrent infections, with a strength of evidence rated as high 1, 5
For denture-related candidiasis, disinfection of dentures in addition to antifungal therapy is essential, with a reported efficacy of 90% 1

For patients with frequent recurrences, fluconazole 100 mg three times weekly is recommended as suppressive therapy, with a reported efficacy of 80-90% 1
For HIV-infected patients with recurrent oral thrush, effective antiretroviral therapy is the best prophylaxis, with a strength of evidence rated as high 3, 1
For denture wearers, proper denture hygiene and removal at night is important to prevent recurrence, with a reported efficacy of 90% 1

Failure to identify and address underlying predisposing factors may lead to treatment failure, with a reported failure rate of 20-30% 1
Prolonged or repeated courses of fluconazole can lead to development of resistance, particularly in immunocompromised patients, with a reported resistance rate of 10-20% 3, 1
Non-albicans Candida species may emerge with intrinsic reduced azole susceptibility after repeated antifungal exposure, with a reported emergence rate of 5-10% 3, 1
Esophageal involvement should be suspected in patients with oral thrush who report odynophagia, retrosternal pain, or difficulty swallowing, with a reported incidence of 10-20% 3